Capital Group’s $107 Million Investment in Intas Pharmaceuticals

Michael Patrini Asia & Pacific, Asia & Pacific Legal Chronicle

The Hong Kong office of Debevoise & Plimpton has advised Capital Group in its acquisition of an equity stake in Intas Pharmaceuticals Limited (“Intas”), one of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Michael Patrini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here